Clinical trial
Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and…
NCT00004811 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00004811 |
|---|---|
| Title | Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH University of Alabama at Birmingham |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Histoplasmosis, Sporotrichosis, Blastomycosis |
| Intervention type | Drug |
| Interventions | itraconazole |
| Enrollment | 7 |
| Start date | Mar 1, 1985 |
| First posted | Feb 25, 2000 |
| Last update posted | Jun 9, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: